Skip to content

Clinical trials

Phase 1/2 Squamous Cell Carcinoma of Head and Neck trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 1/2 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20141
20151
20191
20212
20221
20232
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting3
Terminated2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen1
Bristol-Myers Squibb1
Daiichi Sankyo1
Dynavax Technologies Corporation1
Eli Lilly and Company1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Genmab1
Innate Pharma1
Janssen Research & Development, LLC1
Merus B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck12
Melanoma4
Carcinoma, Non-Small-Cell Lung3
Colorectal Neoplasms3
Head and Neck Neoplasms3
Ovarian Neoplasms3
Uterine Cervical Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Transitional Cell2
Endometrial Neoplasms2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.